August 2008
M T W T F S S
« Jul   Sep »
 123
45678910
11121314151617
18192021222324
25262728293031

Contact us

Contact us

Fortis Healthworld acquired CRS Health

Fortis Healthworld has acquired CRS Health, a Delhi-based pharma and wellness retail chain. It is also planning to rebrand itself and the pharma chains it acquires in future as Religare Wellness. CRS is the drug retailing arm of the diversified Delhi-based SAK Industries. Though the size of the deal is not big, it is Malvinder Singh and Shivinder Singh’s first acquisition since they sold their pharma company Ranbaxy to Daiichi Sankyo. Fortis will pay around Rs 15 crore to acquire 90% stake in CRS Health. Ravi Rajan & Company was the advisor to the deal. […]

August 14th, 2008

HTMT chalks out $100 mn for foreign acquisitions

Hinduja group company HTMT Global Solutions has set aside $110 million (Rs 440 crore) for acquiring companies abroad. “We have set aside a cash of $110 million for acquisition. We are looking at acquisitions in the US and Europe. Especially in Europe where we have limited presence,” HTMT Global Solutions CFO Anand Vora said. In 2006, HTMT had acquired a US-based BPO firm, Affina, for $30 million. At present, the company offers BPO services in healthcare, BFSI and telecom sectors in the US. […]

August 14th, 2008

Baring to buy 40 pc in RSP Architects

Baring Asia is investing $100 million to pick up 40 per cent stake in RSP Architects & Planners India, thereby marking big buck private equity’s foray into architectural consultancy space, sources said. The Hong Kong fund’s investment values the decade-old Bangalore-headquartered architect at $250 million, or Rs 1,000 crore. RSP India has about 360 employees on board, and is seen as a leading design and engineering architect for the sprawling IT campuses and parks. The firm’s portfolio of works include Microsoft campus in Hyderabad and the International Technology Park at Bangalore, while most of the country’s top real estate players figure in its client list. […]

August 14th, 2008

Famy Care may sell 15% to PE funds

Famy Care, the world's largest contraceptive pill producer based out of India, is planning to divest about 15 per cent of its stake to private equity firms to fund its expansion plans. The company, which is fully owned by JP Taparia and sons Sanjeev and Ashutosh, has initiated discussions with four-five global private equity funds for the stake sale, sources said. Famy Care had recently formed a strategic alliance with the third largest off-patent generic drug maker Mylan Laboratories of the US, to sell 22 women healthcare products in the US market by 2010. Famy Care is one of the world's biggest producers of generic intra uterine device Copper-T and oral birth control pills such as Mala-D. The company also makes various contraception products such as injectables, tubal rings and emergency contraceptives, catering to a $7.5 billion global market for women reproductive health products. […]

August 14th, 2008

July was the worst month for M&A this year

Deal making has shifted gears. The size of an individual merger and acquisition (M&A) deal as well as the number of such deals have plunged significantly this year. While volume has shrunk by 10-20% year-on-year, indicating a clear slowdown on deal street, their values have crashed by 60% for the January-July period due to lack of bulge bracket M&As. Private equity (PE) deals have also hit a low with the total value of transaction dropping to $650 million as against the two-year monthly average of $1-1.5 billion. July was the worst month for M&A this year, 43 deals worth $583.95 million were sealed compared with 51 deals worth $5.35 billion in June. […]

August 14th, 2008